MDB Outcomes
We believe public venture outperforms traditional venture
Outcomes for MDB’s curated public venture companies since 1997
100% Taken Public
100% of companies taken public
via IPO or a public offering
100% Premium
100% of companies trading at
100% premium to IPO price
$1 Billion
Approximately 30% reached
$1 Billion in market value
Acquired by Sanofi
for $2.9B
Idea to $1B peak public
market valuation
Idea to $1B peak public
market valuation
Acquired by Pfizer
for $14B
Idea to $3.5B peak
public market valuation
Source: MDB Capital, 2024. None of the information contained herein is intended to imply that past performance will recur or predict or project the performance of an investment or investment strategy